Cargando…

Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2

The interaction between SARS-CoV-2 Spike protein and angiotensin-converting enzyme 2 (ACE2) is essential to viral attachment and the subsequent fusion process. Interfering with this event represents an attractive avenue for the development of therapeutics and vaccine development. Here, a hybrid appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmad, Sajjad, Waheed, Yasir, Abro, Asma, Abbasi, Sumra Wajid, Ismail, Saba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225399/ https://www.ncbi.nlm.nih.gov/pubmed/34169390 http://dx.doi.org/10.1007/s00894-021-04816-y

Ejemplares similares

Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme
por: Ahmad, Sajjad, et al.
Publicado: (2021)

A computational study to disclose potential drugs and vaccine ensemble for COVID-19 conundrum
por: Ahmad, Sajjad, et al.
Publicado: (2021)

Design of a Multi-Epitopes Vaccine against Hantaviruses: An Immunoinformatics and Molecular Modelling Approach
por: Ismail, Saba, et al.
Publicado: (2022)

Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2
por: He, Ming-Feng, et al.
Publicado: (2022)

An Evolutionary Insight Into the Heterogeneous Severity Pattern of the SARS-CoV-2 Infection
por: Raza, Rabail Zehra, et al.
Publicado: (2022)

Towards a novel peptide vaccine for Middle East respiratory syndrome coronavirus and its possible use against pandemic COVID-19
por: Khan, Salman, et al.
Publicado: (2021)

Pan-Genome-Assisted Computational Design of a Multi-Epitopes-Based Vaccine Candidate against Helicobacter cinaedi
por: Ismail, Saba, et al.
Publicado: (2022)

Development of a Novel Multi-Epitope Vaccine Against Crimean-Congo Hemorrhagic Fever Virus: An Integrated Reverse Vaccinology, Vaccine Informatics and Biophysics Approach
por: Tahir Ul Qamar, Muhammad, et al.
Publicado: (2021)

Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines
por: Azam, Syed Sikander, et al.
Publicado: (2013)

Computational Based Designing of a Multi-Epitopes Vaccine against Burkholderia mallei
por: Irfan, Muhammad, et al.
Publicado: (2022)

Immuno-Informatics Analysis of Pakistan-Based HCV Subtype-3a for Chimeric Polypeptide Vaccine Design
por: Ahmad, Sajjad, et al.
Publicado: (2021)

Identification of potential inhibitors of Zika virus NS5 RNA-dependent RNA polymerase through virtual screening and molecular dynamic simulations
por: Noreen, et al.
Publicado: (2020)

CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2
por: Pei, Gaofeng, et al.
Publicado: (2022)

Rational design of potent anti-COVID-19 main protease drugs: An extensive multi-spectrum in silico approach
por: Ahmad, Sajjad, et al.
Publicado: (2021)

The Pharmacological Activities of Glycyrrhizinic Acid (“Glycyrrhizin”) and Glycyrrhetinic Acid
por: Graebin, Cedric Stephan
Publicado: (2017)

SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development
por: Mehmood, Iqra, et al.
Publicado: (2021)

Rational approaches to discover SARS-CoV-2/ACE2 interaction inhibitors: Pharmacophore-based virtual screening, molecular docking, molecular dynamics and binding free energy studies
por: Yazdani, Mohsen, et al.
Publicado: (2023)

Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine
por: Ismail, Saba, et al.
Publicado: (2020)

The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19
por: Ahmad, Iqrar, et al.
Publicado: (2021)

Discovery of Novel Inhibitors From Medicinal Plants for V-Domain Ig Suppressor of T-Cell Activation
por: Muneer, Iqra, et al.
Publicado: (2021)

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection
por: Luan, Junwen, et al.
Publicado: (2020)

ACE2 partially dictates the host range and tropism of SARS-CoV-2
por: Gao, Shan, et al.
Publicado: (2020)

Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction
por: Xiong, Jiacheng, et al.
Publicado: (2021)

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
por: van de Sand, Lukas, et al.
Publicado: (2021)

Potential inhibitors for blocking the interaction of the coronavirus SARS-CoV-2 spike protein and its host cell receptor ACE2
por: Li, Changzhi, et al.
Publicado: (2022)

Glycyrrhizin through liquorice intake modulates ACE2 and HMGB1 levels—A pilot study in healthy individuals with implications for COVID-19 and ARDS
por: Buder, Felix, et al.
Publicado: (2022)

Whole Proteome-Based Therapeutic Targets Annotation and Designing of Multi-Epitope-Based Vaccines against the Gram-Negative XDR-Alcaligenes faecalis Bacterium
por: Alharbi, Metab, et al.
Publicado: (2022)

Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
por: Prévost, Jérémie, et al.
Publicado: (2021)

Interaction of licorice on glycyrrhizin pharmacokinetics.
por: Cantelli-Forti, G, et al.
Publicado: (1994)

Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences
por: Banerjee, Suvankar, et al.
Publicado: (2023)

Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis
por: Dar, Hamza Arshad, et al.
Publicado: (2020)

SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors
por: Milne, Stephen, et al.
Publicado: (2020)

Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2
por: Bastos, Ruan S., et al.
Publicado: (2023)

Virtual Screening of Natural Chemical Databases to Search for Potential ACE2 Inhibitors
por: Yao, Huiping
Publicado: (2022)

Designing a multi-epitope vaccine against Mycobacteroides abscessus by pangenome-reverse vaccinology
por: Dar, Hamza Arshad, et al.
Publicado: (2021)

Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction
por: Mollentze, Nardus, et al.
Publicado: (2022)

Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2
por: Israeli, Ma’ayan, et al.
Publicado: (2022)

ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
por: Lee, Ivan T., et al.
Publicado: (2020)

Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro
por: Lu, Jiayu, et al.
Publicado: (2021)

Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2
por: Wu, Lili, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_82vh7vpbl8bvrkhrf1o09ktnd1